Pharmacokinetic–Pharmacodynamic Modeling of Severity Levels of Extrapyramidal Side Effects With Markov Elements

A major problem in the treatment of schizophrenic patients with current antipsychotic drugs, mainly acting as dopamine-2 receptor antagonists, is the occurrence of side effects such as extrapyramidal symptoms (EPS). Meta-analyses of summary data of EPS occurrence, and receptor occupancies inferred f...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilla Reddy, V, Petersson, K J, Suleiman, A A, Vermeulen, A, Proost, J H, Friberg, L E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603470/
https://www.ncbi.nlm.nih.gov/pubmed/23835881
http://dx.doi.org/10.1038/psp.2012.9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603470/
https://www.ncbi.nlm.nih.gov/pubmed/23835881
http://dx.doi.org/10.1038/psp.2012.9

Ejemplares similares